Images
Participants
Contact
The coordinator of Chemistry and Pharmacology Programme at IRB Barcelona is presented with the Josef Rudinger Memorial Lecture Award during the European Peptide Symposium, in Sofia, Bulgaria.
The award is in recognition of longstanding contributions to the field.
This Sunday, the European Peptide Society (EPS) is to distinguish the IRB Barcelona chemist Ernest Giralt through the presentation of the Josef Rudinger Memorial Lecture Award, the main prize given by this organisation to specialists in field of peptide chemistry. Prof. Giralt is acknowledged for “his important contributions” to the development of methodologies for peptide (small proteins) synthesis, structural studies, and molecular recognition, and to the use of peptides as drug delivery agents. The Rudinger Memorial Award will be presented at the Opening Ceremony of the 33rd European Peptide Symposium, Sofia, Bulgaria.
This is the 15th Josef Rudinger Memorial Lecture Award, a distinction first presented in 1986. Among previous awardees is the scientist Bruce Merrifield, Nobel Prize in Chemistry for the invention of solid-phase peptide synthesis.
Ernest Giralt is Full Professor at the University of Barcelona. He undertakes his research at IRB Barcelona, where he leads the Design, synthesis and structure of peptides and proteins group and coordinates the Chemistry and Molecular Pharmacology Programme, one of the five programmes at the institute.
Prof. Giralt has published around 350 papers, 16 patents, numerous review articles, and several books that have become references in his field. In 2008, he was accepted into the Royal Academy of Sciences and Arts of Barcelona.
During his career he has received various prizes: Leonidas Zervas Award (1994), Dimitrios Theodoropoulos Memorial Lecture Award (2010), Novartis Chemistry Lectureship Award (2011), and the Premio Nacional de Investigación (2011), the highest scientific award in Spain.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).